PMID- 16571971 OWN - NLM STAT- MEDLINE DCOM- 20060504 LR - 20191210 IS - 0003-3022 (Print) IS - 0003-3022 (Linking) VI - 104 IP - 4 DP - 2006 Apr TI - Halothane does not inhibit the functional coupling between the beta2-adrenergic receptor and the Galphas heterotrimeric G protein. PG - 754-62 AB - BACKGROUND: This study investigated whether halothane affects the functional coupling between the beta2 adrenergic receptor and the alpha subunit of its cognate stimulatory heterotrimeric guanosine-5'-triphosphate (GTP)-binding protein (Galphas). The authors hypothesized that halothane does not affect isoproterenol-promoted guanosine nucleotide exchange at Galphas and hence would not affect isoproterenol-induced relaxation of airway smooth muscle. METHODS: Halothane effects on isoproterenol-induced inhibition of calcium sensitivity were measured in permeabilized porcine airway smooth muscle. Galphas nucleotide exchange was measured in crude membranes prepared from COS-7 cells transfected to transiently coexpress the human beta1 or beta2 receptor each with human short Galphas. A radioactive, nonhydrolyzable analog of GTP, [S]GTPgammaS, was used as the reporter for nucleotide exchange at Galphas. RESULTS: Halothane (0.75 mm, approximately 2.8 minimum alveolar concentration [MAC] in pigs) did not affect isoproterenol-induced inhibition of calcium sensitivity. Isoproterenol caused a time- and concentration-dependent increase in Galphas nucleotide exchange. Halothane, even at concentrations of 1.5 mm (approximately 5.6 MAC), had no effect on basal Galphas nucleotide exchange in the absence of isoproterenol, whereas halothane inhibited isoproterenol-promoted Galphas nucleotide exchange in both the beta1-Galphas and beta2-Galphas expressing membranes. However, the effect was significantly greater on beta1-Galphas coupling compared with beta2-Galphas coupling, with no effect on beta2-Galphas coupling at 2.8 MAC halothane. CONCLUSION: Halothane does not inhibit the biochemical coupling between the beta2 receptor and Galphas and hence does not affect the inhibition of calcium sensitivity induced by isoproterenol. Therefore, halothane should not affect the efficacy of beta2 agonists, as suggested by studies of in vivo animal models of asthma. FAU - Hayashi, Masao AU - Hayashi M AD - Department of Anesthesiology, Mayo Foundation, Rochester, Minnesota 55905, USA. FAU - Penheiter, Sumedha G AU - Penheiter SG FAU - Nakayama, Tetsuzo AU - Nakayama T FAU - Penheiter, Alan R AU - Penheiter AR FAU - Warner, David O AU - Warner DO FAU - Jones, Keith A AU - Jones KA LA - eng GR - HL-45532/HL/NHLBI NIH HHS/United States GR - HL-54757/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Anesthesiology JT - Anesthesiology JID - 1300217 RN - 0 (Anesthetics, Inhalation) RN - 0 (Receptors, Adrenergic, beta-2) RN - 146-91-8 (Guanosine Diphosphate) RN - 37589-80-3 (Guanosine 5'-O-(3-Thiotriphosphate)) RN - EC 3.6.5.1 (GTP-Binding Protein alpha Subunits, Gs) RN - L628TT009W (Isoproterenol) RN - SY7Q814VUP (Calcium) RN - UQT9G45D1P (Halothane) SB - IM MH - Anesthetics, Inhalation/*pharmacology MH - Animals MH - COS Cells MH - Calcium/metabolism MH - Chlorocebus aethiops MH - Dose-Response Relationship, Drug MH - GTP-Binding Protein alpha Subunits, Gs/*drug effects/physiology MH - Guanosine 5'-O-(3-Thiotriphosphate)/metabolism MH - Guanosine Diphosphate/metabolism MH - Halothane/*pharmacology MH - Isoproterenol/pharmacology MH - Receptors, Adrenergic, beta-2/*drug effects/physiology MH - Swine EDAT- 2006/03/31 09:00 MHDA- 2006/05/05 09:00 CRDT- 2006/03/31 09:00 PHST- 2006/03/31 09:00 [pubmed] PHST- 2006/05/05 09:00 [medline] PHST- 2006/03/31 09:00 [entrez] AID - 00000542-200604000-00020 [pii] AID - 10.1097/00000542-200604000-00020 [doi] PST - ppublish SO - Anesthesiology. 2006 Apr;104(4):754-62. doi: 10.1097/00000542-200604000-00020.